Early- to mid-stage trials in people with obesity (with and without type 2 diabetes) have reported substantial average weight reductions over 48 weeks at higher doses, alongside improvements in measures like waist circumference, blood lipids and liver fat in those with metabolic fatty liver disease
The most common side effects are gastrointestinal, especially during dose escalation (e.g., nausea, constipation, diarrhea)
These treatments help regulate appetite, reduce cravings, improve insulin sensitivity, and support healthier energy balance for long-term results
At En Vogue IV Therapy & Wellness, our team understands the importance of medical weight loss plans for our patients
Even small changes in medication absorption can make a difference, she adds
My energy was up, my clothes fit differently, and I was sleeping better than I had in years